SH, Y., MS, B., TW, K., SY, J., & WY, K. (2025). Influence of SARS-CoV-2 variants and corticosteroid use on the effectiveness of baricitinib therapy in critical COVID-19. Critical care (London, England), 29(1), 131. https://doi.org/10.1186/s13054-025-05367-x
Chicago Style (17th ed.) CitationSH, You, Baek MS, Kim TW, Jung SY, and Kim WY. "Influence of SARS-CoV-2 Variants and Corticosteroid Use on the Effectiveness of Baricitinib Therapy in Critical COVID-19." Critical Care (London, England) 29, no. 1 (2025): 131. https://doi.org/10.1186/s13054-025-05367-x.
MLA (9th ed.) CitationSH, You, et al. "Influence of SARS-CoV-2 Variants and Corticosteroid Use on the Effectiveness of Baricitinib Therapy in Critical COVID-19." Critical Care (London, England), vol. 29, no. 1, 2025, p. 131, https://doi.org/10.1186/s13054-025-05367-x.